Chemoinformaics analysis of 1-(1,8-DIHYDROXY-3-METHYLNAPHTHALEN-2-YL)ETHANONE
Molecular Weight | 216.236 | nRot | 1 |
Heavy Atom Molecular Weight | 204.14 | nRig | 41 |
Exact Molecular Weight | 216.079 | nRing | 2 |
Solubility: LogS | -3.022 | nHRing | 0 |
Solubility: LogP | 5.338 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 2 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
nHA | 3 | APOL | 32.1175 |
nHD | 2 | BPOL | 12.9065 |
QED | 0.275 |
Synth | 5.664 |
Natural Product Likeliness | 1.469 |
NR-PPAR-gamma | 0.144 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.997 |
Pgp-sub | 0.019 |
HIA | 0.005 |
CACO-2 | -5.403 |
MDCK | 0.0000182 |
BBB | 0.2 |
PPB | 0.891863 |
VDSS | 1.233 |
FU | 0.102884 |
CYP1A2-inh | 0.063 |
CYP1A2-sub | 0.969 |
CYP2c19-inh | 0.052 |
CYP2c19-sub | 0.958 |
CYP2c9-inh | 0.024 |
CYP2c9-sub | 0.478 |
CYP2d6-inh | 0.021 |
CYP2d6-sub | 0.962 |
CYP3a4-inh | 0.054 |
CYP3a4-sub | 0.952 |
CL | 9.101 |
T12 | 0.365 |
hERG | 0.954 |
Ames | 0.085 |
ROA | 0.145 |
SkinSen | 0.87 |
Carcinogencity | 0.026 |
EI | 0.004 |
Respiratory | 0.301 |
NR-Aromatase | 0.632 |
Antiviral | No |
Prediction | 0.677812 |